Ombion Centre for Animal-free Biomedical Translation celebrates launch and site opening

On July 7, 2025, the Ombion Centre for Animal-free Biomedical Translation was officially launched and opened its location at Utrecht Science Park. The centre promotes the transition to animal-free medical innovations and collaborates with over 60 partners on research, education, and practical implementation.
On 7 July 2025, the Centre for Animal-free Biomedical Translation, supported by the Dutch National Growth Fund, was officially launched under its new name: Ombion Centre for Animal-free Biomedical Translation.
The launch of Ombion took place during a festive event in presence of many guests at the Life Sciences Incubator building at Utrecht Science Park. It also marked the opening of Ombion’s on-site centre at the same location. The opening of the centre and the unveiling of the new name and logo was performed by Marten van den Berg, Director General Agriculture of the Ministry of Agriculture, Fisheries, Food Security and Nature, together with Daniela Salvatori, Ombion’s Scientific Director ad interim.
The Ministry of Agriculture, Fisheries, Food Security and Nature originally submitted the CPBT National Growth Fund proposal, which was granted last year. This has now resulted in the establishment of the centre. In his speech, Director General van den Berg underlined the ministry’s support for the Ombion Growth Fund initiative and its goals.
The afternoon program also included pitch-style presentations of Ombion’s main projects and activities, highlighting the various organisations collaborating within the public-private partnership and the involved disease models.
After the presentations, an information market featuring research materials and demonstrations of the projects that are part of the Ombion programme inspired attendees, followed by a lively networking session that concluded the event.
Start of operational phase
The launch is an important milestone for Ombion as it is also the starting point of its operational phase. Initially, the main focus of the centre will be on four transition projects, demonstrating the benefits of animal-free translation techniques in specific medical research fields: ALS, Cystic Fibrosis, Osteoarthritis & Rheumatoid Arthritis, and Asthma & COPD. The new centre will also offer education, training, advice, and support to enhance the acceptance and use of animal-free biomedical innovations. With all activities combined, Ombion will run an integrated programme that accelerates the transition to animal-free translation and strengthens the earning capacity of the Netherlands.
Daniela Salvatori commented: “Today marks a pivotal moment as we officially open the centre and launch our partnership, united by a shared mission to accelerate the transition to animal-free biomedical translation. The energy in the room was truly inspiring – a reflection of the passion and commitment driving this initiative forward. I am looking forward to see the community grow, and I hope that our private and public partnership will consolidate and be open to new projects and initiatives, both nationally and internationally.”
Partnership
Within Ombion, over 60 partners representing academia, research organisations, industry, regulatory organisations, government bodies, patient organisations, NGOs, and others are working together to pave the way for the transition to animal-free biomedical translation. Founding partners of Ombion are Utrecht University, HU University of Applied Sciences Utrecht, UMC Utrecht, UMCG, and Maastricht University.
About Ombion Centre for Animal-free Biomedical Translation
Ombion Centre for Animal-free Biomedical Translation is a national centre for valorising and disseminating animal-free innovations and expertise. It aims to improve and accelerate the transition of new biomedical innovations to patients and users, at lower costs, and without the use of animals. This will lead to safer, more effective, and better medicines while reducing animal testing. Together with a large number of national and international partners, Ombion will work on the development and dissemination of animal-free biomedical innovations and expertise.

Laigo Bio at Utrecht Science Park raises €11.5 million in investments
Laigo Bio, a start-up located at Utrecht Science Park in the Life Sciences Incubator building, announced today that it has raised €11.5 million in investments from a large number of leading investors.

Ronald McDonald House Utrecht presents plans for new, larger House with 50 rooms
Ronald McDonald House Utrecht is building for the future. At Utrecht Science Park, next to the Wilhelmina Children’s Hospital and within walking distance of the Princess Máxima Center, Ronald McDonald House Utrecht has advanced plans to build a brand new, sustainable House with 50 guest rooms. Preparations are well underway, and construction is scheduled to begin in the second half of 2026. The goal is to open the new House sometime in 2028. This expansion will allow the House to offer more families of seriously ill or care-intensive children a warm home, allowing them to be close to their sick child day and night.

Renewal and sustainability UMC Utrecht
In the coming years, most of the UMC Utrecht will be renovated, rebuilt or newly constructed. Many of our buildings are already nearly forty years old and require renovation and sustainability.

Utrecht Science Week anniversary edition a great success
The fifth edition of Utrecht Science Week was a resounding success! With more programs, locations, speakers, and visitors than ever before, we look back on an exciting week. The variety of programs and the diverse audience were wonderful to witness. This way, the groundbreaking research here at Utrecht Science Park isn’t kept behind closed doors, but is given the opportunity to inspire others.